|
Vol. 35 Nº 3 |
Lat. Am. J. Pharm. 35 (3): 425-636 (2016) |
REGULAR ARTICLES |
|
|
Determination and Pharmacokinetic Study of Gefitinib in Rat Plasma by HPLC *
WANG Y., REN K., YAO Y., ZHANG R., ZHOU J., & ZHENG H. (429)
|
|
|
|
Development and Validation of a HPLC-MS/MS Method for the Determination of Azelnidipine in Human Plasma and Application to a Bioequivalence Study *
ZHANG Y., CHEN X., SHI L., YUAN G., ZHANG R., WANG B. & GUO R. (434)
|
|
|
|
Design of Novel Thiazole Bearing Pyrazole Derivatives and Their Dual Activities as ACE Inhibitors and Calcium Channel Blockers in Cardiovascular Disease *
JIANG C., YUAN Z., WANG J., FU J., JIANG G. & ZHENG L. (440)
|
|
|
|
Incidence, Risk Factors, and Main Features of Hospital Admissions Due to Adverse Drug Reactions in Four Departments of a Chinese Hospital *
ZHU M., TANG Z., GUO D., WANG W., WANG D., PEI F., CHEN C., & LIU W. (450)
|
|
|
|
Post Market In Vitro Release Profile Study and Cost Comparison of Different Nicorandil Brands Available in Karachi, Pakistan *
IFFAT W., SHOAIB M.H., YOUSUF R.I., ALI T., & SHAKEEL S. (457)
|
|
|
|
Preparation and Biodistribution of 99mTc-Cloxacillin as a Novel Agent for Imaging Infection Caused by Staphylococcus aureus *
QADIR M.A., SHAHZADI S.K., JAVED M., SHAHZAD S. & AWAN N. (468)
|
|
|
|
The Metabolic Action of Oxybutynin in the Perfused Rat Liver Can Be Explained as a Diminution of the Accessible Cell Space *
COMAR J.F., SUZUKI-KEMMELMEIER F., PERALTA R.M. & BRACHT A. (474)
|
|
|
|
Formulation and Evaluation of Fast Dissolving Tablets of Amlodipine Besylate by Using Sublimation Method *
SONAWANE L.V., POUL B.N. & TIPPANBONE P.M. (481)
|
|
|
|
Potential Use of Solid Lipid Nanoparticles for Transdermal Delivery of Acetyl Salicylic Acid *
DESHPANDE K.B. & MASTIHOLIMATH V.S. (489)
|
|
|
|
Evaluation of the Clinical Effect of Thymopeptide Enteric-Coated Tablets in the Treatment of Erosive Lichen Planus *
PAN H., MA J., GUO H., GU H. & LI J. (496)
|
|
|
|
Exploring the Antibacterial Target of the Main Constituent of Pogostemon cablin by using Molecular Docking and Network Analysis *
TANG Z., XIE X., HUANG W., LENG H., WANG B., HAN B. & PENG C. (502)
|
|
|
|
Vincamine Protects PC12 Cells Against Hydrogen Peroxide Induced Apoptosis by Upregulation of SO and Activation of the PI3K/Akt Pathway *
WU L., WU X., WANG K. & ZHANG J. (510)
|
|
|
|
In Vitro and In Vivo Evaluation of Hydroxypropylmethylcellulose Based Matrix Tablets of Prazosin HCl *
SARKAR M.K., GHOSH T.K., GOSWAMI N., BISWAS N. & ROY N. (519)
|
|
|
|
Design and Development of Novel 1,3,5-Triazine Acetamides as Local Anaesthetics Agents *
LI P., ZHAO Q., WANG S. & LU Y. (529)
|
|
|
|
Design and Discovery of Novel Thiazole Acetamide Derivatives as Anti-HIV Agent Towards AIDS Treatment Via Inhibition of Reverse Transcriptase *
JIANG Y., ZHANG X. & JIANG W. (537)
|
|
|
|
A UPLC-MS/MS Method for Determination of Schaftoside in Rat Plasma and its Application to Pharmacokinetic Study *
CAI J., ZHU L., XU Y., ZHANG W., YANG J., ZHANG C., TAO X., WEN C. & TIAN W. (545)
|
|
|
|
Pharmacokinetic Study of Tenacissoside H in Rat Plasma by Ultra Performance Liquid Chromatography Tandem Mass Spectrometry *
LEI X., ZHOU G., FAN L., GU K., HU Y., ZHANG M., YUAN Q., XU H., ZHANG K. & MA J. (551)
|
|
|
|
Enhanced Intestinal Permeability of Quercetin Coated Felodipine Beads in Wistar Rats. Formulation and Ex Vivo Study *
BHANDARI A., ATTARI Z., MUSMADE P. & LEWIS S. (558)
|
|
|
|
Daucosterol Protects MC3T3-E1 Cells against H2O2-induced Injury via Regulating IGF-1 Pathway *
CUI M., QU J., CHEN S., CHEN H. & ZHOU H. (564)
|
|
|
|
Synthesis, Characterization and Biological Activity of 5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3- d]pyrimidine Derivatives as the Epidermal Growth Factor Recepter Inhibitors *
SUN B., ZHANG J., YIN X., XU Y., ZHANG F., HUANG Y., WANG J., WANG G. & HU C. (570)
|
|
|
|
Development and Validation of a LC-MS Assay for Quantification of CI-994 (N-acetyldinaline) in Rat Plasma and its Application to a Pharmacokinetic Study *
CHEN Y., HE Y., YANG S., LIN Y., LIN Z., ZHANG Q., WEN C. & CHEN T. (578)
|
|
|
|
Application of the Theory of Planned Behavior to Pharmaceutical Practice: Translation and Validation of an Instrument To Predict the Provision of Pharmaceutical Services to Brazilian Portuguese *
JÚNIOR E.H., HALILA G.C., REIS W.C.T., GUANAES L.D., PONTAROLO R. & CORRER C.J. (586)
|
|
|
|
Pharmacokinetics and Bioavailability Study of Chidamide in Rat by Liquid Chromatography Mass Spectrometry *
WANG Y., XU Y., ZHOU H., CHEN D., ZHOU S., ZHANG Q., SHI J., WEN C. & TIAN W. (593)
|
|
|
SHORT COMMUNICATIONS |
|
|
Anti-Cancer Drug Irinotecan-Induced Intestinal Damage Alters the Inhibition Properties of Andrographolide towards UGT2B7 *
LIN L., WANG S., ZHAO L. & TAN G. (599)
|
|
|
|
Preparation and Evaluation of Di-Component and Tri-Component Molecular Inclusion Complexes of Silymarin *
ANSARI, M.J. (604)
|
|
|
|
Metabolic Evaluation of Anti-Lung Cancer Drug Picroside-I *
HE R., KONG L., MENG X., SUN H., ZHANG F. & MA Z. (609)
|
|
|
|
Synthesis and Anti-Congestive Heart Failure Activity of Two Novel Pyran Annulated Heterocyclic Compounds Containing a Triphenylamine Group *
QIN J., SHI P., WANG W., LI Y., HOU B. & WANG Y. (612)
|
|
|
|
Monkey Is the Suitable Animal Model for Pharmacoketic Study of Schisanhenol in Humans *
JYE J., ZHANG H., ZHANG Z., HOU Q. & CUI X. (616)
|
|
|
|
Albumin's Influence towards Hepatic Metabolism and Metabolism-Related Drug-Drug Interaction with Aurantio-Obtusin *
JIN X., LUO D., MA M., YANG Z., HOU J., WU S. & FU N. (620)
|
|
|
|
Synthesis of Dihydropyran Derivatives and Evaluation of Their Antibacterial Activities *
DING J. & WANG C. (625)
|
|
|
|
Carprofen Enantiomers' Inhibition Towards Human Carboxylesterase 1 (Hces1) *
ZHAO Z., ZHANG H., YANG X., TIAN Z., HOU C., & CUI X. (629)
|
|
|
|
The Substrate and Inhibitor Properties of Cerebrovascular Disease Treatment Drug Picroside-II *
HE G., SUN S., ZUO Q., GONG X., GAO Y., HUANG X. & JI Y. (634)
|
|
|
_________________
* English
** Portugûes
|
|
|
ACTIONS ___ ___ _
Submit Article
Check Manuscript Status
Suscription
Free Sample Issue
STATISTICS ___ ___
JCR Impact Factor 2019:
0.240
Issues per year: 12
ISSN 0326 2383 (printed ed.)
ISSN 2362-3853 (on line ed.)
NEWSLETTER ___ ___
JOIN |
|